Abstract
Helicobacter pylori infection is acquired mainly during childhood and causes various diseases such as gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue (MALT) lymphoma, and iron deficiency anemia. Although H. pylori infection in children differs from adults in many ways, this is often overlooked in clinical practice. Unlike adults, nodular gastritis may be a pathognomonic endoscopic finding of childhood H. pylori infection. Histopathological findings of gastric tissues are also different in children due to predominance of lymphocytes and plasma cells and the formation of gastric MALT. Although endoscopy is recommended for the initial diagnosis of H. pylori infection, several non-invasive diagnostic tests such as the urea breath test (UBT) and the H. pylori stool antigen test (HpSA) are available and well validated even in children. According to recent data, both the 13C-UBT and HpSA using enzyme-linked immunosorbent assay are reliable non-invasive tests to determine H. pylori status after eradication therapy, although children younger than 6 years are known to have high false positives. When invasive or noninvasive tests are applied to children to detect H. pylori infection, it should be noted that there are differences between children and adults in diagnosing H. pylori infection.
Helicobacter pylori infection is one of the most common infectious diseases in children and adults [1]. The majority of H. pylori infection in adults is the result of infection during childhood [2]. Because natural eradication is rare, infection is sustained a lifetime unless appropriate treatment for infection is applied [34]. Although H. pylori is mainly acquired in childhood and most of the infected individuals are initially asymptomatic, H. pylori infection is clinically important because it may cause a variety of gastrointestinal diseases, including gastritis, gastric or duodenal ulcer, mucosa-associated lymphoid tissue (MALT) lymphoma, and gastric cancer throughout the patient's lifetime [35]. Additionally, H. pylori infection is also associated with extraintestinal problems such as subnormal growth, malnutrition, and iron deficiency anemia, especially in children [5]. For these reasons, the diagnosis and the treatment of H. pylori infection in children are of great importance.
There is a large body of evidence indicating that H. pylori infection in children differs from that in adults. The differences include epidemiology, pathogenesis and host response, clinical features, related diseases, diagnosis, as well as treatment strategies. Therefore, there are limits to directly applying the findings of adult studies to childhood H. pylori infection, a topic with insufficient scientific literature. In the past, noninvasive diagnostic methods have been used in children despite their relatively low diagnostic accuracy since invasive investigations like endoscopy are difficult to apply to infants or young children. However, with the development of medical technology, endoscopy can be more easily implemented than before, even in infancy, and various noninvasive methods have been developed and validated for the diagnosis of H. pylori infection in children.
In this article, updates on the differences between children and adults in the diagnosis of H. pylori infection will be systematically reviewed and summarized.
Like adults, diagnostic testing for H. pylori infection in children is recommended when the patients have the first-degree relatives with gastric cancer, rather than to solely determine the presence or absence of H. pylori infection itself [5]. However, children with refractory iron deficiency anemia without any other known cause may also be considered for H. pylori testing, as per the evidence-based guidelines from European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) and North American Society for Paediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) for H. pylori infection in children [5].
For the initial diagnosis of the presence of H. pylori, rapid urease test, culture for H. pylori, and tissue staining using gastric tissues obtained by endoscopy of the upper gastrointestinal tract are required to confirm H. pylori infection in both adults and children [56]. With regard to histological examination, it is necessary to collect at least two tissue samples from the gastric antrum and the body, according to evidence-based guidelines for H. pylori infection in children [5]. The collected tissues are stained with hematoxylin-eosin to determine the presence and severity of inflammation, atrophy, and intestinal metaplasia of the gastric mucosa, on the basis of the updated Sydney classification on the histopathology of gastritis [7]. Most H. pylori are found in high density in the antrum. Special staining, such as Warthin-Starry silver stain, Giemsa stain, and Genta stain and immunohistochemistry, lend much help to the diagnosis of H. pylori infection [57].
When performing a rapid urease test and histopathological examination of the biopsy samples, it is recommended, if possible, that the culture for H. pylori be obtained at the same time. When histology and rapid urease tests are both positive or when the culture for H. pylori is positive, it is reasonable to diagnose H. pylori infection in children according to the guidelines from ESPGHAN and NASPGHAN [5]. If the result of histopathological examination and rapid urease testing do not match, diagnosis is determined by carrying additional non-invasive tests such as the urea breath test (UBT) or the H. pylori stool antigen (HpSA) test [5].
Endoscopic findings of gastric mucosa infected with H. pylori in children are distinct from those seen in adults. If H. pylori infection occurs during childhood, it coexists with epithelial cells during the patient's lifetime and leads to chronic gastritis. If colonization continues even in asymptomatic children, the severity of lesions that appear in the gastric mucosa can get worse [8].
If there are nodular changes in the antrum or erosions and ulcers in the duodenum on endoscope, H. pylori infection should be suspected in children [5]. Nodular gastritis, referred to as antral nodularity, nodular antritis, gastric lymphoid hyperplasia, follicular gastritis, or lymphofollicular gastritis, is a common endoscopic manifestation of H. pylori infection in children, with a gross appearance of gooseflesh-like markings on the gastric mucosa [910]. In chronic H. pylori infection of childhood, numerous small nodules are observed on the endoscope in 44-67% of H. pylori-infected children [9], in contrast to 0.19% of adults according to a previous study [11]. The adult study revealed that nodular gastritis was accompanied by peptic ulcers or gastric cancers in about 13% of the patients [11].
On the other hand, nodular gastritis on endoscopy of the upper gastrointestinal tract indicates that H. pylori will be identified in about 90% of the gastric mucosa in children. Therefore, it may be a pathognomonic endoscopic finding of childhood H. pylori infection with relatively high specificity and low sensitivity, for a high grade H. pylori colonization and chronic active gastritis [912]. Although the mechanisms underlying nodular gastritis in children is not clear yet, it is thought that lymphoid follicles with germinal center form nodules on gastric mucosa or that inflammatory reaction associated with H. pylori infection results in an exaggerated appearance of a normal gastric mucosa [13].
As in adults, diagnosis of H. pylori infection in children is made on the basis of histopathological examination, rapid urease test, and culture for H. pylori using gastric tissues [6]. Standard histopathological investigation of the gastric tissue includes observation for the presence and severity of inflammation, atrophy, and intestinal metaplasia on the basis of the updated Sydney classification [7]. In a previous study that compared histopathological parameters of H. pylori-associated gastritis in children with those findings in adults, the degree of chronicity, the activity of gastritis and the summed gastritis score, were not significantly different [14]. However, children with antral nodularity had significantly higher histological scores, suggesting that antral nodularity may be the important sign of higher grade gastritis in young children [14]. In another study by Gallo et al. [15], histological findings of gastric mucosa were also compared between children and adults, and higher severity of gastritis was significantly associated with higher density of H. pylori and cagA-positive strains.
Main histological features of acute gastritis associated with H. pylori infection are surface epithelial degeneration and polymorphonuclear cell infiltration [16]. Differences in immune response to H. pylori infection between children and adults are responsible for the differences in the histological findings of chronic gastritis associated with childhood H. pylori infection between children and adults. Acute active inflammation (infiltration of neutrophils) is less prominent in children compared to adults, while chronic inflammation (infiltration of lymphocytes and plasma cells) is more prominent [171819]. Furthermore, unlike adults, there is a significant correlation between endoscopic findings of nodular gastritis and histological findings demonstrating enlargement of lymph follicles in pediatric patients with H. pylori infection [10].
In contrast to adults, atrophy and intestinal metaplasia are rare, while gastric cancer and MALT lymphoma are known to be extremely rare in children [20]. However, a study reported a significantly higher prevalence of gastric atrophy and low-grade intestinal metaplasia in H. pylori-infected children compared to H. pylori-uninfected children [21]. Since both gastric atrophy and intestinal metaplasia are considered as premalignant lesions [22], it would be useful to apply an updated Sydney classification to all children suspected of H. pylori infection and to eradicate H. pylori in the early stages of infection [21].
Although MALT lymphoma is a rare disease in childhood, a previous study reported that histopathological findings of nodular gastritis caused by H. pylori infection were similar to those of early stage gastric MALT lymphoma, suggesting that these changes may indicate a high risk for gastric MALT lymphoma [23]. Our recent study also revealed that nodular gastritis on endoscopy indicates gastric MALT on histology of gastric tissues in children with H. pylori infection and that the degree of antral nodularity, density of H. pylori, neutrophil activity, and gastritis score correlated with MALT grades, producing a recommendation for gastric MALT evaluation in cases of H. pylori–infected children that manifest severe nodular gastritis on endoscopy [10].
As gastric malignancy is rare in childhood, the implementation of upper gastrointestinal endoscopy is often not necessary. In addition, endoscopy is a relatively invasive method that may cause complications or inflict psychological burden on children and their parents. Thus, there are limitations to using endoscopy on children, especially after the eradication of H. pylori. For this reason, the need for non-invasive diagnostic method with high diagnostic accuracy has been raised. Some non-invasive methods to diagnose H. pylori infection without endoscopy have been developed and these include the UBT, HpSA test, and H. pylori antibody tests in serum, urine, or saliva [524].
In the past, H. pylori immunoglobulin G (IgG) antibody test was commonly used in clinical practice and for epidemiologic studies. However, high rate of false negative results and low diagnostic accuracy has greatly reduced the value of serology. Meanwhile, non-invasive 13C-UBT and HpSA test have been well validated and used primarily in children [524].
UBT is a good example of a non-invasive diagnostic test that can be performed safely and easily, for it does not require an experienced examiner and costs less when compared to endoscopy. It is known as a convenient and accurate test for confirming the presence of H. pylori infection a non-invasive manner in both adults and children. Diagnostic accuracy of the UBT is high, with a sensitivity and specificity of about 95%, even in children, according to a recent meta-analysis [25].
In particular, the sensitivity and the specificity of the UBT reach almost 100% after the eradication therapy of H. pylori in children. Hence the guidelines from ESPGHAN and NASPGHAN for H. pylori infection in children indicated 13C-UBT as the most reliable noninvasive method in lieu of endoscopy to confirm the eradication of H. pylori in children [524].
However, in children less than 6 years of age, clinical application of UBT is somewhat limited because of relatively low specificity and high rate of false positive results compared to adults and older children [252627]. False positive was 8.3% in children younger than 6 years of age compared to 0.85% in children older than 6 years according to our previous study [27]. There are several possible explanations for high false positive results in children younger than 6 years [262728]. UBT measures the isotopic ratio of 13CO2/12CO2, and endogenous CO2 production differs according to age, gender, body weight and height. Therefore, the ingestion of an identical amount of 13C-urea in both adults and children may increase the isotopic ratio of 13CO2/12CO2 in young children compared to adults. In previous studies, including ours, urea hydrolysis rate corrected for the effects of age, weight and height, was suggested as providing a better result than a conventional cutoffs using a delta over baseline [2829]. Another explanation for high false positive results is the presence of urease-producing microorganisms such as Streptococcus salivarius, Proteus mirabilis, and Klebsiella pneumoniae that live in the oral cavity, as young children tend to retain 13C-urea in the mouth [30]. This was supported by a study that compared direct administration of 13C-urea through nasogastric or gastrostomy tubes and administration by oral ingestion [31]. There are additional ways to reduce the false positive results in young children. Young children are encouraged to rinse their oral cavity with fluids after ingesting 13C-urea to reduce degradation by oral flora [5]. It might be useful to apply the optimal cutoff of 7.0‰ to children less than 6 years of age, whereas conventional cutoff 2.4-4.0‰ is applied to adults and children aged 6 years or older [27].
HpSA using enzyme-linked immunosorbent assay (ELISA) methods is also a non-invasive method to detect H. pylori infection with high diagnostic accuracy for adults and children of any ages [32]. It appears to be a useful method for follow-up after eradication therapy [33]. Accordingly, guidelines from ESPGHAN and NASPGHAN for H. pylori infection in children recently recommended the HpSA test using validated ELISA as a reliable test to determine whether H. pylori has been eradicated [5]. According to these guidelines, HpSA test is regarded as more convenient in children than the UBT [5]. In actual fact, it can be easily performed on infants or toddlers merely by collecting stool samples, and there is an added advantage of not requiring expensive equipment such as mass spectrophotometer, as for the UBT.
The conventional HpSA test using ELISA detects H. pylori antigen from the feces using polyclonal antibody or monoclonal antibody [3435363738], and there is a rapid stool antigen test using immunochromatography also available in both adults and children [39404142].
Diagnostic accuracy of HpSA test using ELISA for the initial diagnosis of H. pylori infection in children was high with a sensitivity of 87-100% and specificity of 82-100% as in adults [3536]. Recent two meta-analyses on HpSA tests using monoclonal antibody revealed a pooled sensitivity of 96.2-97% and specificity of 94.7-97% in children, whereas polyclonal HpSA tests revealed a lower diagnostic accuracy with a sensitivity of 88-92% and specificity of 93% [3738].
After the eradication therapy of H. pylori infection, the sensitivity of HpSA decreased from a mean sensitivity of 92.6% before treatment to 80.9% after treatment in children, whereas the sensitivity of HpSA was still high with a mean specificity of 97.2% after treatment according to recent meta-analysis [38].
Rapid stool antigen test using monoclonal antibody is a useful office-based test that can be easily available anytime and anywhere. However, diagnostic accuracy of this one-step HpSA test was relatively lower with a sensitivity of 86-95% and specificity of 88-100% in children, when compared to those by conventional HpSA using ELISA method [373839404142]. Recent two meta-analyses reported a sensitivity of 88.0-88.1% and specificity of 93-94.2% for rapid monoclonal HpSA in children [3738].
Therefore, HpSA using ELISA with monoclonal antibody is the most accurate non-invasive diagnostic method that can replace UBT in children [5].
IgM may rise during the early stages of H. pylori infection, but in the cases of chronic infection, IgA and IgG antibodies are detected in blood, urine, and saliva. Tests to detect antibodies using ELISA have been used mostly for epidemiological studies and research purposes [24], and many tests are available commercially.
The serum H. pylori IgG antibody test may be a useful tool for screening H. pylori infection in adults, but a low sensitivity of 79.2% with a high specificity of 92.4% were reported in young children due to low antibody titers as a result of relatively short infection period and immature immune response to H. pylori in childhood [43444546]. For this reason, the serodiagnosis of H. pylori infection may be inappropriate in young children. Additionally, serum H. pylori IgG antibody test is also inappropriate to monitor H. pylori status after treatment because elevated serum titers of H. pylori IgG antibody persist for a long time [47].
Therefore, as suggested in the guidelines from ESPGHAN and NASPGHAN for H. pylori infection in children, antibody tests for H. pylori in serum, urine, or saliva are not reliable for use in children [5].
Diagnosis of H. pylori infection in children differs from that of adults in many aspects. Unlike adults, nodular gastritis is relatively common and may be indicative of H. pylori infection on endoscopy in children. Moreover, histologic findings tend to show predominance of lymphocytes and the formation of gastric MALT in children. Non-invasive tests such as the UBT and HpSA are preferred in the pediatric population due to excellent diagnostic accuracy before and after H. pylori eradication therapy. As children younger than 6 years tend to have high false positive rates in applying the UBT, HpSA testing is more suitable in this age group.
In conclusion, when invasive or noninvasive tests are applied to children to detect H. pylori infection, clinicians should remember that there are clear differences between children and adults that require appropriate changes to the diagnostic approach.
References
1. Mégraud F. Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am. 1993; 22:73–88.
2. Rothenbacher D, Inceoglu J, Bode G, Brenner H. Acquisition of Helicobacter pylori infection in a high-risk population occurs within the first 2 years of life. J Pediatr. 2000; 136:744–748.
3. Valle J, Kekki M, Sipponen P, Ihamäki T, Siurala M. Long-term course and consequences of Helicobacter pylori gastritis. Results of a 32-year follow-up study. Scand J Gastroenterol. 1996; 31:546–550.
4. Xia HH, Talley NJ. Natural acquisition and spontaneous elimination of Helicobacter pylori infection: clinical implications. Am J Gastroenterol. 1997; 92:1780–1787.
5. Koletzko S, Jones NL, Goodman KJ, Gold B, Rowland M, Cadranel S, et al. ; H pylori Working Groups of ESPGHAN and NASPGHAN. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2011; 53:230–243.
6. Thijs JC, van Zwet AA, Thijs WJ, Oey HB, Karrenbeld A, Stellaard F, et al. Diagnostic tests for Helicobacter pylori: a prospective evaluation of their accuracy, without selecting a single test as the gold standard. Am J Gastroenterol. 1996; 91:2125–2129.
7. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996; 20:1161–1181.
8. Ganga-Zandzou PS, Michaud L, Vincent P, Husson MO, Wizla-Derambure N, Delassalle EM, et al. Natural outcome of Helicobacter pylori infection in asymptomatic children: a two-year follow-up study. Pediatrics. 1999; 104:216–221.
9. Prieto G, Polanco I, Larrauri J, Rota L, Lama R, Carrasco S. Helicobacter pylori infection in children: clinical, endoscopic, and histologic correlations. J Pediatr Gastroenterol Nutr. 1992; 14:420–425.
10. Yang HR, Choi HS, Paik JH, Lee HS. Endoscopic and histologic analysis of gastric mucosa-associated lymphoid tissue in children with Helicobacter pylori infection. J Pediatr Gastroenterol Nutr. 2013; 57:298–304.
11. Miyamoto M, Haruma K, Yoshihara M, Hiyama T, Sumioka M, Nishisaka T, et al. Nodular gastritis in adults is caused by Helicobacter pylori infection. Dig Dis Sci. 2003; 48:968–975.
12. Bahú Mda G, da Silveira TR, Maguilnick I, Ulbrich-Kulczynski J. Endoscopic nodular gastritis: an endoscopic indicator of high-grade bacterial colonization and severe gastritis in children with Helicobacter pylori. J Pediatr Gastroenterol Nutr. 2003; 36:217–222.
13. Riddell RH. Pathobiology of Helicobacter pylori infection in children. Can J Gastroenterol. 1999; 13:599–603.
14. Uhlig HH, Tannapfel A, Mössner J, Jedwilayties S, Deutscher J, Müller DM, et al. Histopathological parameters of Helicobacter pylori-associated gastritis in children and adolescents: comparison with findings in adults. Scand J Gastroenterol. 2003; 38:701–706.
15. Gallo N, Zambon CF, Navaglia F, Basso D, Guariso G, Grazia Piva M, et al. Helicobacter pylori infection in children and adults: a single pathogen but a different pathology. Helicobacter. 2003; 8:21–28.
16. Dixon MF. Histological responses to Helicobacter pylori infection: gastritis, atrophy and preneoplasia. Baillieres Clin Gastroenterol. 1995; 9:467–486.
17. Queiroz DM, Rocha GA, Mendes EN, Carvalho AS, Barbosa AJ, Oliveira CA, et al. Differences in distribution and severity of Helicobacter pylori gastritis in children and adults with duodenal ulcer disease. J Pediatr Gastroenterol Nutr. 1991; 12:178–181.
18. Whitney AE, Guarner J, Hutwagner L, Gold BD. Helicobacter pylori gastritis in children and adults: comparative histopathologic study. Ann Diagn Pathol. 2000; 4:279–285.
19. Mitchell HM, Bohane TD, Tobias V, Bullpitt P, Daskalopoulos G, Carrick J, et al. Helicobacter pylori infection in children: potential clues to pathogenesis. J Pediatr Gastroenterol Nutr. 1993; 16:120–125.
20. Meining A, Behrens R, Lehn N, Bayerdörffer E, Stolte M. Different expression of Helicobacter pylori gastritis in children: evidence for a specific pediatric disease? Helicobacter. 1996; 1:92–97.
21. Kim KM, Oh YL, Ko JS, Choe YH, Seo JK. Histopathology and expression of Ki-67 and cyclooxygenase-2 in childhood Helicobacter pylori gastritis. J Gastroenterol. 2004; 39:231–237.
22. Sipponen P, Kosunen TU, Valle J, Riihelä M, Seppälä K. Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol. 1992; 45:319–323.
23. Ma ZQ, Tanizawa T, Nihei Z, Sugihara K, Nakamura K. Follicular gastritis associated with Helicobacter pylori. J Med Dent Sci. 2000; 47:39–47.
24. Guarner J, Kalach N, Elitsur Y, Koletzko S. Helicobacter pylori diagnostic tests in children: review of the literature from 1999 to 2009. Eur J Pediatr. 2010; 169:15–25.
25. Leal YA, Flores LL, Fuentes-Pananá EM, Cedillo-Rivera R, Torres J. 13C-urea breath test for the diagnosis of Helicobacter pylori infection in children: a systematic review and meta-analysis. Helicobacter. 2011; 16:327–337.
26. Kindermann A, Demmelmair H, Koletzko B, Krauss-Etschmann S, Wiebecke B, Koletzko S. Influence of age on 13C-urea breath test results in children. J Pediatr Gastroenterol Nutr. 2000; 30:85–91.
27. Yang HR, Seo JK. Diagnostic accuracy of the C-urea breath test in children: adjustment of the cut-off value according to age. J Gastroenterol Hepatol. 2005; 20:264–269.
28. Klein PD, Malaty HM, Czinn SJ, Emmons SC, Martin RF, Graham DY. Normalizing results of 13C-urea breath testing for CO2 production rates in children. J Pediatr Gastroenterol Nutr. 1999; 29:297–301.
29. Yang HR, Ko JS, Seo JK. Does the diagnostic accuracy of the 13C-urea breath test vary with age even after the application of urea hydrolysis rate? Helicobacter. 2008; 13:239–244.
30. Jones NL, Sherman PM. Approaching Helicobacter pylori infection in children: level I evidence at last and a word of caution. J Pediatr. 2001; 139:622–623.
31. Peng NJ, Lai KH, Liu RS, Lee SC, Tsay DG, Lo CC, et al. Clinical significance of oral urease in diagnosis of Helicobacter pylori infection by [13C]urea breath test. Dig Dis Sci. 2001; 46:1772–1778.
32. Konstantopoulos N, Rüssmann H, Tasch C, Sauerwald T, Demmelmair H, Autenrieth I, et al. Evaluation of the Helicobacter pylori stool antigen test (HpSA) for detection of Helicobacter pylori infection in children. Am J Gastroenterol. 2001; 96:677–683.
33. Gościniak G, Przondo-Mordarska A, Iwańczak B, Blitek A. Helicobacter pylori antigens in stool specimens of gastritis children before and after treatment. J Pediatr Gastroenterol Nutr. 2003; 36:376–380.
34. Koletzko S, Konstantopoulos N, Bosman D, Feydt-Schmidt A, van der Ende A, Kalach N, et al. Evaluation of a novel monoclonal enzyme immunoassay for detection of Helicobacter pylori antigen in stool from children. Gut. 2003; 52:804–806.
35. Oderda G, Rapa A, Ronchi B, Lerro P, Pastore M, Staiano A, et al. Detection of Helicobacter pylori in stool specimens by non-invasive antigen enzyme immunoassay in children: multicentre Italian study. BMJ. 2000; 320:347–348.
36. Ni YH, Lin JT, Huang SF, Yang JC, Chang MH. Accurate diagnosis of Helicobacter pylori infection by stool antigen test and 6 other currently available tests in children. J Pediatr. 2000; 136:823–827.
37. Leal YA, Cedillo-Rivera R, Simón JA, Velázquez JR, Flores LL, Torres J. Utility of stool sample-based tests for the diagnosis of Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr. 2011; 52:718–728.
38. Zhou X, Su J, Xu G, Zhang G. Accuracy of stool antigen test for the diagnosis of Helicobacter pylori infection in children: a meta-analysis. Clin Res Hepatol Gastroenterol. 2014; 38:629–638.
39. Yang HR, Seo JK. Helicobacter pylori stool antigen (HpSA) tests in children before and after eradication therapy: comparison of rapid immunochromatographic assay and HpSA ELISA. Dig Dis Sci. 2008; 53:2053–2058.
40. Schwarzer A, Lottspeich C, Rüssmann H, Ossiander G, Koletzko S. Evaluation of a novel rapid one-step monoclonal chromatographic immunoassay for detection of Helicobacter pylori in stool from children. Eur J Clin Microbiol Infect Dis. 2007; 26:475–480.
41. Kalach N, Nguyen VB, Bergeret M, Boutros N, Dupont C, Raymond J. Usefulness and influence of age of a novel rapid monoclonal enzyme immunoassay stool antigen for the diagnosis of Helicobacter pylori infection in children. Diagn Microbiol Infect Dis. 2005; 52:157–160.
42. Antos D, Crone J, Konstantopoulos N, Koletzko S. Evaluation of a novel rapid one-step immunochromatographic assay for detection of monoclonal Helicobacter pylori antigen in stool samples from children. J Clin Microbiol. 2005; 43:2598–2601.
43. Czinn SJ. Serodiagnosis of Helicobacter pylori in pediatric patients. J Pediatr Gastroenterol Nutr. 1999; 28:132–134.
44. Graham DY, Evans DJ Jr, Peacock J, Baker JT, Schrier WH. Comparison of rapid serological tests (FlexSure HP and QuickVue) with conventional ELISA for detection of Helicobacter pylori infection. Am J Gastroenterol. 1996; 91:942–948.
45. de Oliveira AM, Rocha GA, Queiroz DM, Mendes EN, de Carvalho AS, Ferrari TC, et al. Evaluation of enzyme-linked immunosorbent assay for the diagnosis of Helicobacter pylori infection in children from different age groups with and without duodenal ulcer. J Pediatr Gastroenterol Nutr. 1999; 28:157–161.